Looking for a COVID-19 test?
CareClues partner hospitals and clinics have been approved by ICMR to conduct COVID-19 RT-PCR test.
Dr. Haseeb Hasan
NeurologistMBBS, MD - General Medicine, DM - Neurology, Fellowship in Epilepsy
Experience: 11 yrsAvailability: Rabindranath Tagore International Institute of Cardiac Sciences
Select a hospital/clinic and book an appointment
124, Eastern Metropolitan Bypass, Mukundapur, Kolkata, 700099
Location is Not Available
Qualifications and Recognitions
Dr. Haseeb Hassan is consultant Neurologist, Epileptologist and Sleep Medicine specialist attached to Narayana Health (RTIICS), Kolkata. With a decade of professional experience, Dr. Hassan is a doctor of high repute and skills. Dr. Hassan studied MBBS from J N Medical College, Aligarh Muslim University, Aligarh followed by training in MD (General Medicine) from Institute of Post Graduate Medical Education and Research, Kolkata. His DM (Doctorate of Medicine) in Neurology and Fellowship in Epilepsy qualifications came through Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum. Furthermore, a comprehensive knowledge about sleep science and sleep medicine was derived through World Sleep Federation Transitional Board Certification achieved by him in 2013. Prior to joining Narayana Health in 2013, Dr. Hassan served as an Assistant Professor of Neurology at Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum. He has taken part in several conferences spanning the areas of Neurology and Epilepsy and showcased scientific papers on the given platform. He also has authored publications in international and national index Neurology and Epilepsy journals. Dr. Hassan has a strong academic and research interest in Epilepsy (Specially Medically Refractory Epilepsy), Sleep Medicine, Neuroelectrophysiology and Stroke. He observes that Epilepsy has become the most prevalent neurological disorder in the country with minimal awareness levels about the disease and its management. There is a stigma attached to the patients suffering from this disease and only 20%-40% epileptic patients get access to the treatment which require years of medical management.